Long-Term Prognosis of Patients With Myocarditis Attributed to COVID-19 mRNA Vaccination, SARS-CoV-2 Infection, or Conventional Etiologies
Patients with post-COVID-19 mRNA vaccination myocarditis, contrary to those with post-COVID-19 myocarditis, show a lower frequency of cardiovascular complications than those with conventional myocarditis at 18 months. However, affected patients, mainly healthy young men, may require medical management up to several months after hospital discharge.
Authors
- Marie-Joëlle Jabagi (ORCID: https://orcid.org/0000-0002-7946-7759)
- Florian Zorès (ORCID: https://orcid.org/0000-0002-6590-0929)
- Jérôme Drouin (ORCID: https://orcid.org/0000-0003-2017-7041)
- Stéphane Le Vu (ORCID: https://orcid.org/0000-0002-1303-8281)
- Marion Bertrand (ORCID: https://orcid.org/0000-0002-4115-7093)
- Rosemary Dray‐Spira (ORCID: https://orcid.org/0000-0001-7646-3667)
- Laura Semenzato (ORCID: https://orcid.org/0000-0002-8305-3487)
- Mahmoud Zureik (ORCID: https://orcid.org/0000-0002-8393-4217)
- Jérémie Botton (ORCID: https://orcid.org/0000-0002-4814-6370)
- Alain Weill (ORCID: https://orcid.org/0000-0001-8687-9092)
- François Cuenot (ORCID: https://orcid.org/0000-0003-4586-4366)
Institutions
- Inserm (FR)
- Université de Versailles Saint-Quentin-en-Yvelines (FR)
- Université Paris-Saclay (FR)
- Centre de recherche en Epidémiologie et Santé des Populations (FR)
- Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail (FR)
Publication Details
- Journal
- JAMA
- Published
- 2024-08-26
- DOI
- https://doi.org/10.1001/jama.2024.16380
- Citations
- 45
- Primary Topic
- Viral Infections and Immunology Research
- Type
- article
- Field-Weighted Citation Impact
- 18.09